Tricida, Inc.

OTCPK:TCDA.Q Lagerbericht

Marktkapitalisierung: US$580.0

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Tricida Management

Management Kriterienprüfungen 3/4

Tricida's CEO is Gerrit Klaerner, appointed in Aug 2013, they has a tenure of 9.83 years. Their total yearly compensation is $4.68M , comprised of 12.8% salary and 87.2% bonuses, including company stock and options. They directly owns 0.68% of the company’s shares, worth $3.93. The average tenure of the management team and the board of directors is 4 years and 9.5 years respectively.

Wichtige Informationen

Gerrit Klaerner

Geschäftsführender

US$4.7m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts12.8%
Amtszeit als Geschäftsführer9.8yrs
Eigentum des Geschäftsführers0.7%
Durchschnittliche Amtszeit des Managements4yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder9.5yrs

Jüngste Management Updates

Recent updates

Tricida enters $125M debt facility

Oct 19

Tricida: Important Binary Event Coming Up

Sep 21

Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)

Sep 14
Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)

Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares

Dec 14
Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares

Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%

Dec 09

Tricida's Veverimer CRL And Regulatory Updates: An Analysis

Nov 17

Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives

Oct 29

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Gerrit Klaerner im Vergleich zu den Einnahmen von Tricida verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2022n/an/a

-US$134m

Jun 30 2022n/an/a

-US$148m

Mar 31 2022n/an/a

-US$153m

Dec 31 2021US$5mUS$600k

-US$177m

Sep 30 2021n/an/a

-US$181m

Jun 30 2021n/an/a

-US$219m

Mar 31 2021n/an/a

-US$244m

Dec 31 2020US$9mUS$598k

-US$265m

Sep 30 2020n/an/a

-US$268m

Jun 30 2020n/an/a

-US$235m

Mar 31 2020n/an/a

-US$213m

Dec 31 2019US$10mUS$584k

-US$177m

Sep 30 2019n/an/a

-US$146m

Jun 30 2019n/an/a

-US$131m

Mar 31 2019n/an/a

-US$120m

Dec 31 2018US$1mUS$503k

-US$103m

Sep 30 2018n/an/a

-US$96m

Jun 30 2018n/an/a

-US$77m

Mar 31 2018n/an/a

-US$60m

Dec 31 2017US$821kUS$425k

-US$41m

Vergütung im Vergleich zum Markt: Gerrit's total compensation ($USD4.68M) is above average for companies of similar size in the US market ($USD747.42K).

Entschädigung vs. Einkommen: Gerrit's compensation has been consistent with company performance over the past year.

Geschäftsführer

Gerrit Klaerner (51 yo)

9.8yrs

Amtszeit

US$4,676,490

Vergütung

Dr. Gerrit Klaerner, Ph.D. Founded Tricida, Inc.and has been its Chief Executive Officer and President since August 2013 and has been its an Executive Director since July 2013. Dr. Klaerner was the Founder...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Gerrit Klaerner
Founder9.8yrsUS$4.68m0.68%
$ 3.9
Geoffrey Parker
COO, CFO & Executive VP6.2yrsUS$2.51m0.72%
$ 4.2
Robert McKague
Executive VP3.3yrsUS$2.43m0.031%
$ 0.2
Dawn Parsell
Executive Vice President of Clinical Development4.8yrsUS$2.77m0.0060%
$ 0.03
Annie Yoshiyama
VP of Finance & Chief Accounting Officer2.5yrskeine Datenkeine Daten
Jackie Cossmon
Vice President of Investor Relations & Communicationsno datakeine Datenkeine Daten
Edward Hejlek
Executive Vice President of Intellectual Property3.3yrsUS$2.10mkeine Daten

4.0yrs

Durchschnittliche Betriebszugehörigkeit

58yo

Durchschnittliches Alter

Erfahrenes Management: TCDA.Q's management team is considered experienced (4 years average tenure).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Gerrit Klaerner
Founder9.9yrsUS$4.68m0.68%
$ 3.9
Kathryn Falberg
Independent Non-Employee Director5.1yrsUS$329.00k0.074%
$ 0.4
Klaus Veitinger
Independent Chairman of the Board9.3yrsUS$379.00k0.20%
$ 1.1
David Hirsch
Independent Non-Employee Director6.9yrsUS$326.50k0.019%
$ 0.1
Robert Alpern
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board9.7yrsUS$314.00kkeine Daten
John Fordtran
Member of Scientific & Clinical Advisory Boardno datakeine Datenkeine Daten
David Bushinsky
Member of Scientific & Clinical Advisory Boardno datakeine Datenkeine Daten
Craig Hawker
Member of Scientific & Clinical Advisory Boardno datakeine Datenkeine Daten
Sandra Coufal
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board9.9yrsUS$316.50k0.15%
$ 0.9
Navdeep Tangri
Member of Scientific & Clinical Advisory Boardno datakeine Datenkeine Daten
Thomas Hostetter
Member of Scientific & Clinical Advisory Boardno datakeine Datenkeine Daten
Bertram Pitt
Member of Scientific and Clinical Advisory Boardno datakeine Datenkeine Daten

9.5yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrener Vorstand: TCDA.Q's board of directors are considered experienced (9.5 years average tenure).